表紙
市場調查報告書

乳房植入市場 - 成長,趨勢,及預測(2019年 - 2024年)

Breast Implant Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 871411
出版日期 內容資訊 英文 115 Pages
商品交期: 2-3個工作天內
價格
Back to Top
乳房植入市場 - 成長,趨勢,及預測(2019年 - 2024年) Breast Implant Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年05月01日內容資訊: 英文 115 Pages
簡介

本報告提供全球乳房植入市場的相關調查,市場概況和成長要素、阻礙因素,各類型、用途、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊彙整。

目錄

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 乳癌的發生率上升
    • 豐胸手術數量的增加
    • 技術的進步
  • 市場阻礙因素
    • 乳房植入的併發症與其相關的風險
    • 高成本
  • 波特五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各類型
    • 矽膠植入
    • 形狀穩定植入
    • 生理食鹽水植入
    • 結構化生理食鹽水植入
  • 各用途
    • 重組手術
    • 美容整形
  • 各終端用戶
    • 醫院
    • 美容診所
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東及非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Allergan PLC
    • Establishment Labs SA
    • GC Aesthetics
    • Groupe Sebbin SAS
    • Laboratories Arion
    • Mentor Worldwide LLC (a Subsidiary of Johnson & Johnson)
    • POLYTECH Health & Aesthetics GmbH
    • Shanghai Kangning Medical Supplies Ltd
    • Sientra Inc.

第7章 市場機會及今後趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 64745

Market Overview

The major factors for the growth of the breast implant market include the rising incidence of breast cancer, an increasing number of breast augmentation procedures, and technological advancements.

Breast cancer is currently the leading cause of cancer-related deaths in women in the world's developing regions. According to the National Cancer Institute, an estimated 252,710 women have been diagnosed with breast cancer in 2017. Furthermore, 230,815 American women were diagnosed with breast cancer in 2013. Over 3.1 million American women have been affected by breast cancer as of March 2017. According to the American Cancer Society, in 2017, an estimated 252,710 new cases of invasive breast cancer were diagnosed among women. In addition, 63,410 cases of in situ breast carcinoma were diagnosed among women. Approximately 40,610 women and 460 men died from breast cancer in 2017 and therefore, the number of breast cancer cases are expected to increase in the coming years. According to the Cancer Research UK, there are around 54,900 new breast cancer cases in the United Kingdom every year, that is around 150 per day (2013-2015). Moreover, it is estimated that the risk of an individual dying from breast cancer would increase in the coming years. Hence, the increase in breast cancer prevalence is a major factor contributing to revenue growth of the breast implant market across the world.

Scope of the Report

As per the scope of this report, breast implants are medical devices that are used to augment the size of breasts, either for cosmetic applications or reconstruction purposes, to correct a congenital abnormality. The procedure involves the usage of breast implants, in order to enhance and improve the size of the breasts. There is an increase in the demand for breast augmentation techniques, globally, that helps in fueling the demand for breast implants in the market.

Key Market Trends

Silicone Implant is the Segment by Drug Class is expected to be Fastest Growing Segment Over the Forecast Period

Silicone gel-filled implants are the silicone shells filled with a plastic gel (silicone). Silicone implants can be inserted through an axillary incision but are not ideal when compared to other locations. Breast implant manufacturers charge around USD 1,000 more for silicone implants than they do for saline. Additionally, it is recommended that women with silicone implants have an MRI three years after their initial surgery and every two years after that. This is the only way to detect ruptures in the implant, which is often not covered by health insurance policies. The silicone gel-filled breast implants are approved for breast augmentation in women of age 22 or older and for breast reconstruction in women of any age. They are also used in revision surgeries, in order to correct or improve the result of an original surgery. Over the last 20 years, significant advances have been made to silicone gel implants. In fact, now surgeons are implanting the 7th and 8th generation of silicone breast implants. The newest silicone implants have a slightly higher fill (96% fill versus the previous generation's 85% fill) and more cross-linking of the silicone molecules, increasing the stiffness or cohesiveness of breast implants. These advances have helped in the growth of silicone breast implants.

North America is Expected to Dominate the Market

North America is found to hold a major share for the Breast Implant Market and is expected to show a similar trend over the forecast period, without significant fluctuations. The major factors contributing to the growth of the market in the United States is the large demand for breast augmentation, coupled with the greater cost of the devices. Breast augmentation is the most popular cosmetic procedure that was being performed in the country, with around 290,467 patients opting for the surgery, according to new statistics released by the American Society of Plastic Surgeons. According to the American Society of Plastic Surgeons, in 2017 there were around 27,507 breast implant removals (augmentation patients only) performed. Thus, such a huge number of cases is expected to drive the growth of the breast implant market. For example, as per the Breastcancer.org, estimates in 2019, 268,600 new cases of invasive breast cancer are expected to be diagnosed in women along with 62,930 new cases of non-invasive breast cancer, in the United States. According to the American Society of Plastic Surgeons, in 2016, the average cost of breast augmentation surgery was USD 3,719 in the country. Thus, owing to the all above-mentioned factors the market is expected to witness high growth over the forecast period.

Competitive Landscape

The market studied is a moderately consolidated market owing to the presence of small and large market players. Some of the market players are Allergan Plc, Establishment Labs SA, GC Aesthetics, Groupe Sebbin SAS, Laboratories Arion, Mentor Worldwide LLC (a Subsidiary of Johnson & Johnson), POLYTECH Health & Aesthetics GmbH, Shanghai Kangning Medical Supplies Ltd, and Sientra Inc.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Incidence of Breast Cancer
    • 4.2.2 Increasing Number of Breast Augmentation Procedures
    • 4.2.3 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Post Complications and Risks Associated with Breast Implants
    • 4.3.2 High Cost of Breast Implants
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Type
    • 5.1.1 Silicone Implant
    • 5.1.2 Form-stable Implant
    • 5.1.3 Saline Implant
    • 5.1.4 Structured Saline Implant
  • 5.2 By Application
    • 5.2.1 Reconstructive Surgery
    • 5.2.2 Cosmetic Surgery
  • 5.3 By End User
    • 5.3.1 Hospital
    • 5.3.2 Cosmetology Clinic
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 US
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 UK
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Allergan PLC
    • 6.1.2 Establishment Labs SA
    • 6.1.3 GC Aesthetics
    • 6.1.4 Groupe Sebbin SAS
    • 6.1.5 Laboratories Arion
    • 6.1.6 Mentor Worldwide LLC (a Subsidiary of Johnson & Johnson)
    • 6.1.7 POLYTECH Health & Aesthetics GmbH
    • 6.1.8 Shanghai Kangning Medical Supplies Ltd
    • 6.1.9 Sientra Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top